O�jectives: Hi�� doses o� c�e�ot�erapy �enerate ��� da�a�e in patients under�oin� �one �arrow transplantation (BMT)� due to t�e production o� reactive oxy�en species (ROS). In order to evaluate t�e local de�ensive e��ectiveness o� t�e patient under�oin� BMT� t�e concentrations o� t�e antioxidants superoxide dis�utase (SO�) and uric acid (U�) were �easured in saliva. Study �esi�n: Basal saliva sa�ples were collected �ro� 20 patients under�oin� BMT at t�e Oncolo�y �epart-�ent� Sanatorio �llende (C�rdo�a)� in t�e sta�es: initial� prior to conditionin� t�erapy (I); �iddle: 7 to 10 days after BMT (M) and final stage, 30 days after discharge from isolation (F). SOD levels were determined using a R���OX kit (R��SO� superoxide dis�utase �anual)� and �or uric acid enzy�atic UO� / P�P spectrop�oto-�etric �et�od� ( Trinder Color Kit � Wiener La�) was used. Results: 85% of the patients developed oral mucositis. SOD concentration in the M stage was significantly higher (p<0.01) compared with stage I, and it reversed in stage F. UA concentration was significantly lower (p<0.001) in sta�e M co�pared wit� sta�e I� and in sta�e � it recovered t�e initial values. Conclusions: SO� increase in sta�e M coincided wit� t�e appearance o� �ucositis� w�ic� could �e interpreted as a de�ensive �ec�anis� o� saliva a�ainst oxidative stress produced �y c�e�ot�erapy. U� decrease in sta�e M would �avour t�e develop�ent o� �i��er de�rees o� �ucositis.
Introduction
Hi��ly i��unosuppressive and toxic treat�ents prior to t�e �one �arrow ste� cells transplantation (BMT) �enerate reactive oxy�en species (ROS)� w�ic� da�a�e t�e ��� o� t�e oral epit�eliu� and su��ucosa. T�is da�a�e �enerates clinical and �istolo�ical alterations in oral �ucosa and periodontal tissues� as well as dys�unctions in t�e salivary �lands and c�an�es in saliva (1) . T�e current literature s�ows isolated and controversial results related to t�e side e��ects o� di��erent oncolo�ic dru�s on t�e oral cavity (2) . Likewise� t�e de�ree o� incidence and severity o� t�e complications is not clear, which makes difficult to consolidate palliative supportive treat�ents o� t�e da�a�e. Most o� t�e antineoplastic dru�s act indiscri�inately on t�e �asal cells o� oral epit�eliu�� alterin� its renewal capacity. T�is� leads to t�e appearance o� a series o� syste�ic and local side e��ects suc� as �ucositis� xerosto�ia� in�ections and �e�orr�a�e. Mucositis is an inflammatory reaction that may affect all t�e �astrointestinal �ucosa� wit� �i�� prevalence in t�e orop�aryn�eal area (3) (4) (5) (6) . Mucositis is associated with a significant increase in the �or�idity� producin� a delay or even t�e interruption o� t�e antineoplastic treat�ent as well as an increase in t�e t�erapeutic costs (7�8). T�e etiopat�o�enesis o� oral �ucositis is not totally clear. However� series o� risk �actors associated wit� its appearance �ave �een descri�ed� w�ic� are related �ainly wit� t�e type o� oncolo�ical treat�ent and wit� patient individual �actors. In patients under�oin� c�e�ot�erapy� t�e incidence and severity o� toxic �ucositis could �e deter�ined �y t�e dose and t�e sc�e�e o� ad�inistra-tion. �or�ally appears 3 to 5 days a�ter t�erapy �as �een started� it reac�es a �axi�u� �etween 7 to 10 days� and resolves in t�e �ollowin� 5 to 7 days� unless it is co�pli-cated �y in�ection or �e�orr�a�e (9�10). Clinical si�ns o� �ucositis include epit�elial atrop�y� erosions and ulcerations o� t�e oral �ucosa� w�ic� increases t�e risk o� syste�ic in�ection. Pain is o�ten intense and could inter�ere wit� �asic oral �unctions suc� as p�ona-tion� swallowin� and eatin� (11)� and in so�e cases it requires t�e ad�inistration o� opioid anal�esics. I��unosuppression induced �y c�e�ot�erapy durin� t�e conditionin� period prior to �one �arrow transplantation secondarily alters t�e capacity to respond to anti�enic sti�uli. T�e severity o� t�e �ucositis in t�ese patients could �e related wit� t�e de�ree o� i��unosup-pression. Reco�nizin� t�e need to develop �ore e��ective and �iolo�ical �ased t�erapies� recent researc� �as �ocused on t�e pat�o�iolo�y o� �ucositis. In its initial p�ase it involves direct da�a�e to ��� and ot�er cell co�po-nents� �eneratin� ROS� w�ic� causes a cascade o� �io-lo�ical events. In order to neutralize t�e�� t�e or�anis� �as power�ul antioxidant syste�s� �ot� enzy�atic and non-enzy�atic (12) . T�e de�ensive �attery provided �y saliva is �ade o� i��unoenzy�atic a�ents suc� as lysozy�e� I� �� salivary a�ylase and antioxidant su�strates wit� a certain catalytic e��ect suc� as peroxidase� Superoxide �is�utase (SO�) and Uric �cid (U�) responsi�le �or 70% o� t�e antioxidant potential o� saliva. T�e presence o� eac� one o� t�ese antioxidants in saliva is conditioned �ainly �y �landular production� especially t�at o� t�e parotid �land as in t�e case o� SO�. T�e verification carried out by Kohen in 1992, that saliva modifies its enzymatic profile according to the humor reducin� needs under t�e circu�stances o� oxidative stress, modified the then prevailing idea that it is a liquid of stable composition (13) . Inflammatory responses provide a �u�e a�ount o� �ree radicals� especially superoxide anion and H 2 O 2 . T�e salivary enzy�atic production o� antioxidants is e�inently o� �landular ori�in� �ein� suscepti�le o� increasin� its concentration in di��erent types o� inflammatory disorders (14, 15) . The identification of antioxidants in tissues, blood and saliva provides an idea o� t�e e��ective local or syste�ic de�ensive syste�s. Based on t�ese antecedents� t�e ai� o� our work was to evaluate t�e e��ective local de�ense o� patients wit� �ucositis under�oin� BMT �y �easurin� salivary antioxidants suc� as SO� and U�.
Material and Methods
� lon�itudinal o�servational study was carried out� in a population o� 20 patients ad�itted to t�e �epart�ent o� Oncolo�y� Sanatorio �llende� durin� 2009-2012� wit� prescription o� BMT. Exclusion criteria �or t�is study were: patients under t�e a�e o� 18 and over t�e a�e o� 80� pre�nant patients� patients wit� previous radiot�erapy w�ic� �ad a��ected t�e cranio�acial area� and tu�ors in t�e �ead and neck. In�or�ed consent was o�tained �ro� eac� participant� t�e study was approved �y t�e Medical Et�ics Co��it-tee o� Sanatorio �llende and it was inscri�ed in REPIS (Provincial Re�ister o� Researc� on Hu�an Healt�) under nu��er 1189 (15/04/09). -T�e �ollowin� oral �ealt� indexes were re�istered: Plaque index ai�ed at quanti�yin� plaque deposits in t�e �in�ival �ar�in (16). Löe and Silness index: to evaluate t�e de�ree o� �in�i-val inflammation (17) . Simplified hemorrhage index: It indicates positive or ne�ative �leedin�� a�ter pro�in� t�e �in�ival sulcus wit� a periodontal pro�e (18) . Sulcus dept� index (<4�� deep) or pocket (= > 4�� deep) o� vesti�ular sur�ace o� t�e dental ele�ents in �ot� arc�es.
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-Sto�atolo�ical exa�ination and saliva collection T�e sto�atolo�ical exa�ination and t�e collection o� saliva sa�ples were carried out at t�e �ollowin� ti�es: �) Initial sta�e: prior to c�e�ot�erapy B) Middle sta�e: durin� t�e isolation period� �etween t�e sevent� and tent� day a�ter BMT. C) Final stage: Thirty days after finishing the isolation period. Sto�atolo�ical exa�ination: an exa�ination o� t�e so�t tissues o� t�e oral cavity and annexed structures was �ade. T�e sto�atolo�ical lesions were se�io�rap�ed and an icono�rap�y o� t�e� was �ade. �ia�nostic and c�aracterization o� �ucositis was per�or�ed �ollowin� t�e WHO scale (19) . -Collection o� �asal saliva: Patients in a fasting state or at the first or second hour a�ter �reak�ast� restin�� sittin� and silent� were asked to was� t�eir �out� wit� distilled water. �or 5 �inutes� t�e saliva t�at �or�ed and accu�ulated in t�e �out� was collected in a disposa�le centri�u�al conic plastic tu�e previously wei��ted. Every patient prior to t�e BMT was considered as control �roup. T�e �aterial o�tained was carried in a �er�etically sealed container wit� �reezin� �el� at -4 C º. T�en it was wei��ted� centri�u�ed� its pH was deter�ined and it was conserved at -18 Cº �or its su�sequent �ioc�e�ical analysis (20) . -Sa�ple analysis: T�ese were processed and analyzed at t�e la�oratory o� t�e P�ysiolo�y C�air� Odontolo�y �aculty� U.�.C. In order to deter�ine SO�� a R���OX kit was used (R��SO� Superoxide �is�utases Manual)� and �or U� an enzy�atic UO� / P�P spectrop�oto�etric �e-t�od (Trinder Color Kit � Wiener La�) was used. Statistical �nalysis: data were analyzed �y Student �T� test �or paired data to co�pare t�e di��erent sta�es o� treat�ent� settin� a P value < 0.05 for statistical significance.
Results
65% O� t�e patients included in t�e sa�ple were �e-�ales. Patients were �etween 27 and 71 years-old� wit� a �ean a�e o� 44 years-old. Ot�er c�aracteristics o� t�e patients included in t�e sa�ple are s�own in ta�le 1. 85% o� t�e patients o�served developed oral �ucosi-tis. In relation to t�e de�ree o� severity� 50% s�owed �ucositis �rade 1� 15.78% �rade 2 and 15�78% �rade 3� w�ile 5.26% s�owed �rade 4. The samples of basal saliva analyzed showed a significant increase o� SO� durin� t�e �iddle sta�e� 2.25 U/ ml ± 1.30 compared to initial 0.73 U/ml ± 0.42 and final 1.67 U/�l ± 0.94 (p<0.01) sta�es (�i�. 1). UA showed a significant decrease in the middle stage 1.17 ��/dl ± 0.22 co�pared to t�e initial 2.28 ��/dl ± 0.5 and final 1.58 mg/dl ± 0.33 stages respectively (p<0.001) (�i�. 2).
Oral �ealt� indexes yielded t�e �ollowin� results: Gingival inflammatory response, evaluated by Löe and Silness rates� increased in t�e �iddle co�pared to t�e initial sta�e (p< 0.01), and reverted by the final stage. The simplified bleeding index did not exhibit statistically significant changes and plaque index revealed an increase in t�e �iddle sta�e co�pared wit� t�e initial sta�e. �ept� index o� t�e vesti�ular sulcus o� anterior and posterior elements significantly increased in the middle p�ase �ut did not revert at t�e end o� t�e treat�ent (p <0.01).
Discussion
The identification of antioxidants in tissues, blood and saliva and other body fluids provides an idea of the local or syste�ic de�ensive e��ectiveness o� t�e individual (21) . In t�is sense� �a�ler et al. state t�at saliva constitutes an i�portant de�ensive line a�ainst oxidative stress (22). Ki� et al. classi�y t�e salivary antioxidants in t�ree large groups, according to their function. The first �roup is �or�ed �y preventive antioxidants� w�ic� are t�ose w�ic� in�i�it t�e production o� �ree radicals� suc� as SO�� carotenoids� catalase� �lutat�ione peroxidase� transferrin, albumin and haptoglobin. Secondly, we find �sweepin�� antioxidants� suc� as vita�in � and E� U�� al�u�in and �iliru�in� w�ic� eli�inate �ree radicals in order to in�i�it t�e startin� and spreadin� o� cell da�-a�e. �inally� enzy�es suc� as proteases� trans�erase� lipases� etc� repair t�e da�a�e caused in t�e tissues (23) (24) . �a�ler et al. consider t�at t�e antioxidant salivary syste� is �or�ed �y an enzy�atic co�ponent� w�ere t�e �ain exponent is SO� and a non-enzy�atic co�po-nent� represented �ainly �y U�. T�e production o� SO� in saliva is o� �landular ori�in� �ainly parotideal. Ya�a�oto et al. s�owed t�at t�is enzy�e is capa�le o� increasin� in response to di��er-ent inflammatory reactions. In fact, some studies have de�onstrated an increase in t�e concentration o� SO� in processes suc� as tonsillitis� pulpitis� periodontitis and peri-i�plantitis (25) (26) (27) . T�ere are �ew studies corcernin� t�e relations�ip �e-tween SOD and inflammation in the oral cavity or periodontium, and the results are conflicting. Ellis et al. state that a significative reduction of SOD activity was �ound in �in�ival tissue adjacent to deep periodontal pockets (28�29). Ot�er studies �ad indicated t�at total salivary antioxidants activity re�ains at t�e sa�e level in periodontal disease� or is reduced (30�31). Canakci et al. �ad de�onstrated t�at SO� activity �ot� in saliva was lower in patients wit� periodontal disease co�-pared to �ealt�y su�jects (32) . On t�e ot�er �and� Wei et al. stated that SOD was significantly �i��er in t�e c�ronic periodontitis patients co�-pared to t�e �ealt�y patients o� t�e control �roup (33) . e447 Nagler studied the antioxidant profile of human saliva in �ealt�y adults and deter�ined t�at nor�al SO� values are 0.79 U/�l �or �asal saliva y 0.80 U/�l �or t�e sti�ulated one. In our work on oncolo�ic patients� we observed a significant increase in the identifications o� SO� durin� t�e �iddle sta�e� coincidin� wit� t�e �e�innin� o� clinical �ani�estations o� oral �ucositis. T�is increase in t�e concentration o� SO� could �e interpreted as a de�ense �ec�anis� o� saliva a�ainst oxidative stress produced �y c�e�ot�erapy at �i�� doses e�ployed durin� t�e conditionin� sta�e prior to �one �arrow transplantation. Considerin� t�e results o� ot�er �roups as we discussed a�ove� we consider t�at t�is increased activity o� SO�� at least in part� also �ay �e due to t�e c�an�es in periodontal indexes durin� t�e �iddle sta�e. However� re- 
Conclusions
T�e deter�ination o� t�e salivary concentrations o� antioxidants suc� as SO� and U� provides a non-invasive �et�od w�ic� allows evaluatin� t�e de�ensive capacity o� t�e oral �ucosa in oncolo�ic patients under treat�ent wit� c�e�ot�erapy dru�s at �i�� doses. �t t�is study� t�e increase o� t�e levels o� SO� in patients t�at developed �ucositis could �e interpreted as a de�ense �ec�anis� in t�e presence o� t�e injury t�at c�e�ot�erapy represents to t�e cells o� t�e oral �ucosa� w�ile a decrease o� U� would allow t�e startin�� pro�ression and t�e tissue da�a�e. By virtue o� t�e results o�tained� we consider t�at it is necessary to do �uture researc� w�ic� per�it to o�tain �urt�er knowled�e a�out t�ese and ot�er antioxidant su�-stances in saliva and its correlation wit� oral �ucositis. T�e inte�ration o� dentists in t�e oncolo�y tea� �e-co�es i�portant in t�e study� prevention� dia�no-sis and treat�ent o� t�e oral co�plications� in order to i�prove t�e quality o� li�e in patients under�oin� c�e�ot�erapy.
